Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Abernethy, R
731  Ergebnisse:
Personensuche X
?
1

Indentation testing on 3 MeV proton irradiated tungsten:

Rayaprolu, R. ; Möller, S. ; Abernethy, R....
Nuclear Materials and Energy.  25 (2020)  - p. 100776 , 2020
Link: https://doi.org/10.1016/..
 
?
2

STATE OF THE CLIMATE IN 2017:

BLUNDEN, J. ; HARTFIELD, G. ; ARNDT, D. S....
Bulletin of the American Meteorological Society.  99 (2018)  8 - p. Si-S310 , 2018
Link: https://www.jstor.org/st..
 
?
3

Tyrosine kinase-targeting drugs-associated heart failure:

Gronich, N ; Lavi, I ; Barnett-Griness, O...
British Journal of Cancer.  116 (2017)  10 - p. 1366-1373 , 2017
Link: https://doi.org/10.1038/..
 
?
4

Application of Systems Pharmacology to Explore Mechanisms o..:

Shon, J ; Abernethy, D R
Clinical Pharmacology & Therapeutics.  96 (2014)  5 - p. 536-537 , 2014
Link: https://doi.org/10.1038/..
 
?
5

Use of Internet Search Logs to Evaluate Potential Drug Adve..:

Sarntivijai, S ; Abernethy, D R
Clinical Pharmacology & Therapeutics.  96 (2014)  2 - p. 149-150 , 2014
Link: https://doi.org/10.1038/..
 
?
6

High-Risk Prescribing and Incidence of Frailty Among Older ..:

Gnjidic, D ; Hilmer, S N ; Blyth, F M...
Clinical Pharmacology & Therapeutics.  91 (2012)  3 - p. 521-528 , 2012
Link: https://doi.org/10.1038/..
 
?
7

Needs for an Expanded Ontology-Based Classification of Adve..:

Zhichkin, P E ; Athey, B D ; Avigan, M I.
Clinical Pharmacology & Therapeutics.  91 (2012)  6 - p. 963-965 , 2012
Link: https://doi.org/10.1038/..
 
?
8

Integration of Diverse Data Sources for Prediction of Adver..:

Abernethy, D R ; Bai, J P F ; Burkhart, K..
Clinical Pharmacology & Therapeutics.  90 (2011)  5 - p. 645-646 , 2011
Link: https://doi.org/10.1038/..
 
?
9

BSR and BHPR guidelines on the use of rituximab in rheumato..:

Bukhari, M. ; Abernethy, R. ; Deighton, C....
Rheumatology.  50 (2011)  12 - p. 2311-2313 , 2011
Link: https://doi.org/10.1093/..
 
?
10

Pharmacoepidemiology in the Postmarketing Assessment of the..:

Hilmer, S. N. ; Gnjidic, D. ; Abernethy, D. R.
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences.  67A (2011)  2 - p. 181-188 , 2011
Link: https://doi.org/10.1093/..
 
?
11

Pharmacological Mechanism-Based Drug Safety Assessment and ..:

Abernethy, D R ; Woodcock, J ; Lesko, L J
Clinical Pharmacology & Therapeutics.  89 (2011)  6 - p. 793-797 , 2011
Link: https://doi.org/10.1038/..
 
?
12

BSR and BHPR rheumatoid arthritis guidelines on eligibility..:

Deighton, C. ; Hyrich, K. ; Ding, T....
Rheumatology.  49 (2010)  6 - p. 1197-1199 , 2010
Link: https://doi.org/10.1093/..
 
?
13

BSR and BHPR rheumatoid arthritis guidelines on safety of a..:

Ding, T. ; Ledingham, J. ; Luqmani, R....
Rheumatology.  49 (2010)  11 - p. 2217-2219 , 2010
Link: https://doi.org/10.1093/..
 
?
14

BSR and BHPR rheumatoid arthritis guidelines on eligibility..:

Deighton, C. ; Hyrich, K. ; Ding, T....
Rheumatology.  , 2010
Link: https://doi.org/10.1093/..
 
?
15

Pediatric Dose Selection:

Abernethy, D R ; Burckart, G J
Clinical Pharmacology & Therapeutics.  87 (2010)  3 - p. 270-271 , 2010
Link: https://doi.org/10.1038/..
 
1-15